The Co-Editors-in-Chief of Cardiovascular Innovations and Applications (CVIA), Jamie B. Conti, University of Florida, Gainesville, FL, USA, Jianzeng Dong, Beijing Anzhen Hospital, Capital Medical University, Beijing, China and Jun Pu, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, are pleased to announce that the 2023 Journal Impact Factor (JIF) for CVIA is 0.9.

Submissions to Cardiovascular Innovations and Applications (CVIA) can be made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Articles of interest include:

Machine Learning Methods in Real-World Studies of Cardiovascular Disease

Experience in Application of a Three-Dimensional Pulsed Field Ablation System Integrating Mapping and Ablation

Association between Percentage of Neutrophils at Admission and in-Hospital Events in Patients ≥75 Years of Age with Acute Coronary Syndrome

Feasibility of an Integrated Digital and Pharmacological Approach Targeting Blood Lipids in Atherosclerotic Cardiovascular Disease Management

Heart Failure Guideline Directed Medical Therapy: Which One and When?

Long-term Effects of Nicorandil Combined with Dihydropyridine Calcium Channel Blockers on Cardiovascular Outcomes in Patients with Coronary Heart Disease: A Real-world Observational Study

Transcatheter “Sandwich” Valve-in-Valve Implantation Technique for Pure Aortic Regurgitation: Operation Skills and Early Experience

Advances in Renal Denervation in the Treatment of Hypertension

Overview of Postural Orthostatic Tachycardia Syndrome (POTS) for General Cardiologists

​

Cardiovascular Innovations and Applications is indexed in the SCOPUS, EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life, CNKI Scholar (Chinese National Knowledge Infrastructure) and Ulrich’s web Databases.